期刊文献+

术前Fib-4指数对肝癌肝切除术后复发的预测价值 被引量:4

Predictive value of preoperative Fib-4 index on postoperative recurrence of hepatocellular carcinoma after hepatectomy
下载PDF
导出
摘要 目的评价肝癌患者术前Fib-4指数对肝癌肝切除术后复发的预测价值。方法回顾性分析67例行肝部分切除肝癌患者的临床资料,根据患者术前Fib-4指数的大小分为低指数组(Fib-4指数<3.25)和高指数组(Fib-4指数≥3.25),术后应用门诊、电话方式随访,以Cox回归模型对术后复发情况进行相关因素分析。结果单因素分析提示,术前AFP≥400μg/L、肿瘤最大直径>5 cm、肿瘤数目>3个、Fib-4指数≥3.25、血管侵犯及切缘阳性、门静脉癌栓是影响肝癌肝切除术后无瘤生存的危险因素(P均<0.05),Cox回归分析显示术前Fib-4指数≥3.25、肿瘤数目>3个及门静脉癌栓是肝癌术后复发的独立危险因素(P均<0.05)。结论术前Fib-4指数≥3.25是影响肝癌患者术后复发的独立危险因素。 Objective To investigate the postoperative recurrence predictive value of preoperative Fib-4 index on hep- atocellular carcinoma patients. Methods Clinical data of 67 cases of hepatoeellular carcinoma underwent hepatectomy in the 5th Hospital Affiliated to Sun Yat-sen University were analyzed retrospectively. According to the preoperative Fib-4 in- dex, these patients were divided into 2 groups, one was Fib-4 index 〈3.25, the other was Fib-4 index≥3.25. These pa- tients were follow-up visited by using outpatient service and telephone till 2013 September. Cox ratio risk pattern analysis was used for the recurrent correlative factors. Results Univariate analysis showed that preoperative AFP≥400 ug/L, the maximum diameter of the tumor 〉 5cm, the number of tumor 〉 3, Fib-4 index ≥ 3.25, vascular invasion, positive resection margin and portal vein tumor thrombus were all risk factors of poor disease-free survival ( all P 〈 0.05 ). Cox regression a- nalysis revealed that Fib-4 index≥3.25, the number of tumor 〉 3 and portal vein tumor thrombus were independent predic- tors of poor disease-free survival after hepateetomy for hepatocellular carcinoma ( all P 〈 0.05 ). Conclusion Preoperative Fib-4 index≥3.25 is an independent risk factor for predicting the postoperative recurrence of patients with hepatocellular carcinoma.
出处 《山东医药》 CAS 2014年第17期4-6,共3页 Shandong Medical Journal
基金 广东省自然科学基金博士科研启动项目(10451008901004816)
关键词 肝肿瘤 Fib-4指数 术后复发 hepatocellular carcinoma Fib-d index postoperative recurrence
  • 相关文献

参考文献9

二级参考文献38

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2Yun-Chung Cheung,Sheung-Fat Ko,Shu-Hang Ng,Siu-Cheung Chan.Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-lipiodol mixture in treating hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(18):2792-2795. 被引量:4
  • 3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 4陈荣新,叶胜龙,樊嘉,吴志全,周俭,邱双健.肝动脉化疗栓塞对原发性肝癌伴门静脉癌栓的治疗作用[J].中华肿瘤防治杂志,2006,13(7):530-531. 被引量:11
  • 5Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy[J]. J Hepatol, 2003,38(2):200-207.
  • 6Nazario P, Arianna C, Sara G, et al. Early and late recurrence after liver resection for hepatocellular carcinoma[J]. Ann Surg, 243(2):229-235.
  • 7Sterling RK,Lissen E,Clumeck N,et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.Hepatology.2006,43:1317-1325.
  • 8Cedes P,Oberti F,Michalak S,et al.A novel panel of blood markers to assess the degree of liver fibrosis.Hepatotogy,2005,42:1373-1381.
  • 9Adams LA,Bulsara M,Rossi E,et al.Hepascore:an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.Clin Chem,2005,51:867-873.
  • 10Poynard T,Mona R,Halfon P,et al.Meta-analyses of FibroTest diagnostic value in chronic liver disease.BMC Gastroenterol,2007,7:40.

共引文献87

同被引文献40

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部